The short answer
Testicular cancer is highly curable, with around 95% five-year survival. Surveillance means checkups, blood markers and scans on a schedule, and the anxiety around scans is real and common.
SEER reports five-year relative survival for testicular cancer of 94.6% (2016 to 2022), with about 9,810 diagnoses and 630 deaths estimated for 2026 and a median age at diagnosis of 33.
NCI describes surveillance as close follow-up with no treatment unless test results change.
Surveillance uses tumor markers (AFP, beta-hCG, LDH), checkups and scans, including CT of the abdomen and pelvis.
Seminomas do not produce AFP, and LDH has limited value for predicting relapse in seminoma.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
This page is for men on surveillance after testicular cancer. It explains what the checkups involve and offers ways to cope with the worry before scans.
Start with the outcome
Testicular cancer is among the most treatable cancers there is. SEER puts five-year relative survival in the United States at 94.6% for cases diagnosed between 2016 and 2022. The American Cancer Society projects about 9,810 new diagnoses and 630 deaths in 2026 (published in SEER Stat Facts). The median age at diagnosis is 33.
That context belongs at the front. Surveillance can make a situation feel more precarious than it is. NCI describes surveillance as closely following your condition without giving treatment unless test results change. It is not a decision to do nothing. It is a plan to check carefully and treat if something changes.
What surveillance actually involves
Your team will follow you on a schedule. NCI says men treated for testicular cancer have a higher risk of cancer in the other testicle, so regular self-exams and reporting anything unusual matter.
Blood markers. Alpha-fetoprotein (AFP), beta human chorionic gonadotropin (beta-hCG) and lactate dehydrogenase (LDH). Seminomas do not produce AFP. NCI notes that LDH has limited value for predicting relapse in seminoma. Ask which markers are useful for your tumor type.
Imaging. For stage I seminoma managed without immediate extra treatment, the NCI PDQ describes chest x-rays and CT scans of the abdomen and pelvis. The pattern is every 4 months for the first 3 years, then every 6 months for 3 years, then yearly for 4 more years.
Schedules differ by tumor type and stage. Ask for your own schedule in writing.
Scanxiety is common
The dread that builds around a scan, and while waiting for results, is called scanxiety. A scoping review of 36 studies found it affects people during treatment and after it. The wait between the scan and the result was described as particularly stressful. Anxiety often dropped right after the scan itself.
Naming it helps. Dread around a scheduled scan is a common reaction to uncertainty. It is not a sign of what the result will be. If it is hard to manage, or you notice new symptoms, tell your care team.
Things that shrink the gap
- Ask for the scan and the results appointment to be booked close together, and ask before you leave how long the wait will be.
- Decide in advance how you want results delivered. Some people want portal access the moment it posts. Others want to hear it from a person first. Tell your team which you are.
- Book the scan at a time that limits empty waiting, and plan something concrete for the day results are due.
- Tell one person your dates, so you are not carrying it silently.
- Keep your own copy of the schedule and your marker values. Watching your own numbers stay flat is often steadying.
If something does turn up
For stage I seminoma on surveillance, NCI says about 15 to 20 percent have a recurrence. Nearly all respond to radiation or chemotherapy, with cure rates approaching 100 percent. Ask your team what the options would be for your tumor type.
Sources
Common questions
Why am I not being given chemotherapy or radiotherapy as a precaution?
NCI lists surveillance as an option: close follow-up with no treatment unless test results change. Ask your team why it fits your tumor type and stage, and what would trigger treatment.
My marker went up slightly. Does that mean relapse?
Ask your team what the change means for your tumor type. NCI notes that LDH has limited value for predicting relapse in seminoma, so your team will weigh markers together with your exam and scans.
Should I be worried about radiation from repeated CT scans?
It is a reasonable thing to ask about. Ask your team what your scan schedule is, how long it runs, and whether any other imaging option is suitable for you.
Does the anxiety mean something is actually wrong?
Scanxiety is common and does not predict the result. A scoping review of 36 studies found the wait between the scan and the result was often the most stressful part, and anxiety often eased right after the scan itself. If your worry is hard to manage, or you notice new symptoms, tell your care team.
How long does surveillance go on?
It depends on tumor type and stage. For stage I seminoma, the NCI PDQ describes scans about every 4 months for the first 3 years, then every 6 months for 3 years, then yearly for 4 more years. Ask for your own schedule in writing.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-08-13 what this meansLast updated: 2026-10-02Next planned review: 2027-07-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- A Symptom Is Not a Diagnosis
- What Symptoms Should I Call My Oncology Team About Today?
- Questions to Ask Before Cancer Treatment Begins
- Blood Cancer & 'Watch and Wait' (Active Surveillance)
- Brain Tumor Seizures, Memory & Mood Management
- HER2-Positive Breast Cancer Targeted Therapies
- Kidney Cancer (RCC) Post-Surgery Surveillance
- Leukemia Treatment Isolation & Neutropenic Safety